News

Sanofi granted FDA label expansion for MenQuadfi meningococcal shot for infants
Sanofi (SNY) wins FDA label expansion for its MenQuadfi meningococcal vaccine for use in infants as young as six weeks. Read ...
MedPage Today8d
RFK Jr. Threatens Publishing Ban; Obesity Drug Costs Fall; Nurses' Brain Tumor Probe
HHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...
Sanofi (SNY)’s MenQuadfi Becomes First MenACWY Vaccine Approved for Ages 6 Weeks and Up
The U.S. FDA has approved an expanded indication for Sanofi (NASDAQ:SNY)’s quadrivalent meningococcal vaccine, MenQuadfi, now ...
US FDA approves use of Sanofi's meningococcal vaccine in infants
French drugmaker Sanofi said the U.S. Food and Drug Administration has approved its meningococcal vaccine for use in infants ...
Yahoo Finance23d
Sanofi (SNY): A Bull Case Theory
Meanwhile, flu vaccines—anchored by deep public-sector distribution—generated €2.25 billion, and MenQuadfi, a meningitis vaccine, posted 50.5% growth. Despite some expected erosion in older ...
contemporarypediatrics29d
INF108 to prevent necrotizing enterocolitis receives FDA designations
In a May 7, 2025 announcement, Infinant Health stated that its investigational drug candidate INF108 received both orphan drug and rare pediatric disease designations for the prevention of necrotizing ...
contemporarypediatrics29d
PKU and the pediatrician with Suzanne Hollander, MS, RD, LDN
In this interview, Suzanne Hollander, MS, RD, LDN, discusses the importance of collaborative care in PKU and the impact of a new potential treatment. As the phenylketonuria (PKU) community anticipates ...